These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26506065)

  • 41. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing the clinical attributes of abobotulinumtoxinA and onabotulinumtoxinA utilizing a novel contralateral Frontalis model and the Frontalis Activity Measurement Standard.
    Nestor MS; Ablon GR
    J Drugs Dermatol; 2011 Oct; 10(10):1148-57. PubMed ID: 21968665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.
    Yu KC; Nettar KD; Bapna S; Boscardin WJ; Maas CS
    Arch Facial Plast Surg; 2012; 14(3):198-204. PubMed ID: 22183059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M; Andersson M; Punga AR
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin to minimize facial scarring.
    Jablonka EM; Sherris DA; Gassner HG
    Facial Plast Surg; 2012 Oct; 28(5):525-35. PubMed ID: 23027220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports.
    Isaac CR; Chalita MR; Pinto LD
    Arq Bras Oftalmol; 2012; 75(3):213-4. PubMed ID: 22872208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.
    Carruthers A; Bruce S; Cox SE; Kane MA; Lee E; Gallagher CJ
    Aesthet Surg J; 2016 May; 36(5):591-7. PubMed ID: 26979457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport).
    Dover JS
    Aesthet Surg J; 2017 May; 37(suppl_1):S1-S3. PubMed ID: 28388716
    [No Abstract]   [Full Text] [Related]  

  • 51. Botulinum toxin in men: review of relevant anatomy and clinical trial data.
    Keaney TC; Alster TS
    Dermatol Surg; 2013 Oct; 39(10):1434-43. PubMed ID: 24090254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Depressor anguli oris sign (DAO) in facial paresis. How to search it and release the smile (technical note)].
    Labbé D; Bénichou L; Iodice A; Giot JP
    Ann Chir Plast Esthet; 2012 Jun; 57(3):281-5. PubMed ID: 22647640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
    Allen SB; Goldenberg NA
    Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical cosmetic Botox techniques.
    Carruthers J; Carruthers A
    J Cutan Med Surg; 1999 Dec; 3 Suppl 4():S49-52. PubMed ID: 11749899
    [No Abstract]   [Full Text] [Related]  

  • 55. AbobotulinumtoxinA: A 25-Year History.
    Monheit GD; Pickett A
    Aesthet Surg J; 2017 May; 37(suppl_1):S4-S11. PubMed ID: 28388718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis.
    Galvin R; Callaghan C; Chan WS; Dimitrov BD; Fahey T
    Semin Arthritis Rheum; 2011 Jun; 40(6):585-7. PubMed ID: 21397930
    [No Abstract]   [Full Text] [Related]  

  • 57. Horizontal animation deformity as unusual complication of neurotoxin modulation of the gummy smile.
    Chen G; Oranges CM; Giordano S; Huang R; Wang W
    Dermatol Online J; 2019 Aug; 25(8):. PubMed ID: 31553868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining fillers and neuromodulators in the same syringe.
    Cohen JL; Mariwall K
    J Drugs Dermatol; 2013 Sep; 12(9):976. PubMed ID: 24002142
    [No Abstract]   [Full Text] [Related]  

  • 59. Combining fillers and neuromodulators in the same syringe.
    Kenner J
    J Drugs Dermatol; 2014 Feb; 13(2):110. PubMed ID: 24509957
    [No Abstract]   [Full Text] [Related]  

  • 60. An unusual adverse event of botulinum toxin injection in the lower face.
    Auada Souto MP; Souto LRM
    J Cosmet Dermatol; 2021 May; 20(5):1381-1384. PubMed ID: 33249739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.